Multi-drug Resistant Tuberculosis

Treatment of Tuberculosis Multidrug Resistance Treatment of Tuberculosis Multidrug Resistance

TBTC Study 30: Safety and Tolerability of Low Dose Linezolid in MDR TB

Innovating(IN) Shorter(S), All- Oral, Precised(P), Individualized(I) Treatment Regimen(RE) for Rifampicin Resistant Tuberculosis(INSPIRE-TB)

Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Single-dose Study in Two Panels of Healthy Adult Participants to Assess Immediate-Release and Dispersible Formulations of Pretomanid

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Economic Evaluation of New MDR TB Regimens

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Safety and Effectiveness of Delamanid-containing Regimen for MDR-TB Patients in China

New Genomic Techniques and Management of Multidrug-resistant Tuberculosis

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment Trial

An Open-label RCT to Evaluate a New Treatment Regimen for Patients With Multi-drug Resistant Tuberculosis

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

PRACTECAL-PKPD Sub Study

Case Control Study of Vitamin D Status and Adult Multidrug-resistant Pulmonary Tuberculosis in Maharashtra, India

A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)

MDR-TB Close Contacts Tracing in China (TCCT Study)